Prochlorperazine Maleate Market Size is valued at USD 1.5 Bn in 2024 and is predicted to reach USD 2.0 Bn by the year 2034 at a 3.2% CAGR during the forecast period for 2025-2034. Prochlorperazine maleate is an antipsychotic medicine in the phenothiazine class. It is mostly used to treat symptoms including acute nausea and vomiting, vertigo, and some mental health concerns. The dosage of prochlorperazine varies depending on the condition being...
Report ID: 2047 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 170
Nanoparticle Formulation Market Size is valued at 5.87 billion in 2024 and is predicted to reach 13.74 billion by the year 2034 at an 9.0% CAGR during the forecast period for 2025-2034. Nanoparticles are particles in the nanometer scale from 1 to 100 nm in diameter. These particles have proven helpful in many areas, including biomedicine, commonly for implants & drug delivery. Drug delivery with nanoparticles is an exciting field in which ...
Report ID: 1883 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Sulfasalazine Market Size is valued at USD 2.2 Bn in 2024 and is predicted to reach USD 3.5 Bn by the year 2034 at a 5.0% CAGR during the forecast period for 2025-2034. Sulfasalazine, an anti-inflammatory drug, used to treat inflammatory gut diseases like Crohn's disease and ulcerative colitis. In the body, sulfasalazine aids in reducing inflammation. Sulfasalazine contains two active components: sulfapyridine and 5-aminosalicylic acid (5-ASA)...
Report ID: 2018 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
The Global Curative Therapeutics Market Size is predicted to witness a 7.8% CAGR during the forecast period for 2025-2034. Curative therapies, also known as curative treatments or curative measures, are medical treatments that aim to provide a permanent cure for a particular disease or condition. Curative therapies, as opposed to palliative or symptomatic treatments that focus on managing symptoms and enhancing the quality of life, aim to elim...
Report ID: 1893 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Peptide and Anticoagulant Drugs Market Size is predicted to develop with a 5.0% CAGR during the forecast period for 2025-2034. Blood thinners are anticoagulants, which are chemical agents that decrease blood coagulation and the time it takes for blood to clot. Anticoagulants are a type of medicine that is used to treat thrombotic disorders. Oral anticoagulants are available in pill, tablet, and injectable forms. Heparin is an injectable antico...
Report ID: 1837 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Global Constrained Peptide Drugs Market Size is valued at USD 1.5 Bn in 2024 and is predicted to reach USD 6.7 Bn by the year 2034 at an 16.3% CAGR during the forecast period for 2025-2034. Polypeptide chains with cyclic rings make up cyclic peptides. The ring structure can be created by joining the ends of the peptide together with an amide bond or another chemically stable bond such as lactone, ether, thioether, disulfide, and so on. Many biol...
Report ID: 1944 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Global Immune-Mediated Inflammatory Diseases Market Size is estimated to grow at a 7.10% CAGR during the forecast period for 2024 to 2031. Immune-Mediated Inflammatory Diseases Market Size, Share & Trends Analysis Report By Treatment Type (Traditional Drugs, Biologic Therapies, Novel Therapies), Indication (Asthma, Chronic Obstructive Pulmonary Diseases (COPD), Inflammatory Bowel Disease (IBD), Systemic Lupus Erythematosus (SLE), Rheumatoid ...
Report ID: 2889 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 165
Global Combination Vaccines Market Size is valued at USD 5.2 Bn in 2024 and is predicted to reach USD 12.7 Bn by the year 2034 at a 9.6% CAGR during the forecast period for 2025-2034 The growth of the market for combination vaccines is being driven by an increase in the world's pediatric population. In addition, a different factor, such as the prevalence of infectious diseases, is favorably affecting market expansion. The frequency of viral dise...
Report ID: 1919 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Global Nutraceutical Contract Manufacturing Services Market Size is valued at USD 157.0 Bn in 2024 and is predicted to reach USD 414.4 Bn by the year 2034 at a 10.4% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: There is a rising consumer preference for preventive healthcare and natural remedies, leading to increased demand for a wide range of nutraceutical products. This trend is driving...
Report ID: 1780 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
PCOS Diagnostic Market Size is predicted to witness a 5.0% CAGR during the forecast period for 2025-2034. PCOS (polycystic ovarian syndrome) is a hormonal condition affecting many women of reproductive age. PCOS is characterized by irregular or prolonged menstrual cycles as well as high levels of male hormones. Although there is no cure for PCOS, various medications are used to regulate the menstrual cycle and manage the condition's symptoms. ...
Report ID: 1758 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Pharmaceuticals